Massachusetts Lawmakers Reach Deal To Double Marijuana Possession Limit And Restructure Cannabis Regulations

Massachusetts lawmakers have negotiated the details of a bill to double the legal marijuana possession limit for adults and revise the regulatory framework for the state’s adult-use cannabis market.

A bicameral conference committee has spent months working out provisions of the legislation after the House of Representatives and Senate passed differing versions last year, and the panel approved a compromise approach on Monday.

Sen. Adam Gómez (D) and Rep. Daniel M. Donahue (D), who co-chaired the conference committee, said in a joint statement that the agreement “charts a more promising path forward for cannabis regulation in our Commonwealth.”

“The legislation includes a new structure that provides clear accountability and enhances the operations of the Cannabis Control Commission (CCC),” the lawmakers, who also serve as co-chairs of the legislature’s Joint Cannabis Policy Committee, said. “The bill creates new opportunities for small businesses to grow, while providing those historically harmed by marijuana laws with temporary, exclusive access to those opportunities. This bill will allow them to realize their capital and pursue innovative models such as employee-owned businesses.”

If approved in its final form by both chambers, which Gómez and Donahue said they expect to happen this week, the bill would then head to Gov. Maura Healey (D) for her signature.

Gómez said at Monday’s conference committee meeting that the agreement represents “a forward-looking approach to modernize Massachusetts’s cannabis laws at a high level.”

“This legislation recognizes that our cannabis industry has matured and that our regulatory framework must involve along with them,” he said.

“The bill strengthens oversight and accountability by restructuring the Cannabis Control Commission, streamlining its leadership and clarifying goals and responsibilities so that the agency can operate more efficiently and transparently. We also make important improvements to public accountability by creating a new portal for reporting illegal conduct, requiring updated reporting on public health impacts and tax policy and studying workplace safety standards. The bill ensures that the industry continues to operate in a way that prioritizes safety, transparency and public trust.

This legislation also supports economic opportunity and long-term sustainability by modernizing license caps and providing more flexibility in ownership structures. We help businesses—especially small and emerging operators—remain viable in the competitive market and by expanding pathways for participation by social equity businesses, including exclusive opportunities in the medical marijuana space. We reinforce our commitment to fairness and equitable access. We remove outdated and burdensome requirements such as the vertical integration mandate for medical operators that have created barriers to entry into growth. These changes help level the playing field and ensure that our cannabis economy reflects the diversity and the dynamics of the Commonwealth.

Additionally, the bill expands safe and legal access to cannabis. It updates purchase and possession limits, it clarifies delivery rules to create consistency across municipalities and also allows for more modern and reasonable advertising practices within regulated environments. Finally, we take the important steps to address emerging issues in the marketplace, such as regulation of hemp-derived products and categories by directing further study and thoughtful policy development.”

Among the proposed revisions to the state’s cannabis law is a section that would increase the personal possession limit for marijuana from one to two ounces. Colorado enacted the same reform in 2021 after that state’s cannabis market matured.

In addition to the possession increase, which was included in both chambers’ versions, H.4206 would reduce the size and revise the organization of CCC, while also updating limits on marijuana business licensing.

Under both chambers’ versions of the bill, CCC would be comprised of three members rather than the current five. The conference committee report adopts provisions from the House measure that would allow the governor to make all appointments, rather than the Senate approach to give one of the appointments to the attorney general. Under current law, the treasurer also plays a role in appointing commission members, but that will no longer be the case if the legislation is enacted.

The new legislation requires that one member of CCC to have a background in social justice, while the other two commissioners need to have backgrounds in public health, public safety, social justice, consumer regulations or the production and distribution of cannabis.

The bill will also increase the amount of licenses that a single entity can possess from three to six, while additionally raising from 10 percent to 20 percent the threshold of much equity in a business is considered ownership for the purpose of counting toward the cap on licenses.

It also directs regulators to create a list of  “delinquent” cannabis businesses that have not paid their debts to other operators for more than 60 days and prevents others from doing business with those on the delinquent list until debts are paid off.

—Marijuana Moment is tracking hundreds of cannabis, psychedelics and drug policy bills in state legislatures and Congress this year. Patreon supporters pledging at least $25/month get access to our interactive maps, charts and hearing calendar so they don’t miss any developments.

Learn more about our marijuana bill tracker and become a supporter on Patreon to get access.—

The cannabis regulation proposal’s advancement comes as marijuana businesses in the state have filed a lawsuit aiming to block an initiative to roll back the state’s voter-approved legalization law from reaching the November ballot.

If passed, the state wouldn’t revert back to blanket prohibition; rather, it would repeal the commercial recreational sales and personal home cultivation components of the law while still allowing adults 21 and older to possess up to an ounce of cannabis for personal use.

Possession of more than one ounce but less than two ounces would be effectively decriminalized, with violators subject to a $100 fine. Adults could also continue to gift cannabis between each other without remuneration. Medical marijuana sales would remain legal.

The measure is currently before the legislature after supporters turned in an initial batch of signatures last year, and lawmakers have until May 5 to act on the proposal. If they choose not to enact it legislatively, the campaign would need to go through another round of petitioning and get at least 12,429 certified signatures by July 1 to make the November ballot.

Proponents faced skeptical questioning from lawmakers at a hearing of the Joint Committee on Initiative Petitions last month, with several raising concerns about the motivations behind the anti-marijuana measure and its implications for consumers and businesses.

A recent Bay State Poll from the University of Hampshire’s States of Opinion Project found that a majority of Massachusetts adults oppose the marijuana sales and cultivation repeal initiative.

Meanwhile, in November, the legislature’s Joint Cannabis Policy Committee advanced a bill that would require a study into legal barriers facing first responders who wish to use marijuana in compliance with state law.

Regulators would also need to look into the efficacy of marijuana in the treatment of anxiety, depression and post-traumatic stress disorder (PTSD). They would additionally examine laws and policies for cannabis use by police officers and first responders in other jurisdictions and “any other topics the commission deems relevant.”

The bill was reported out as lawmakers in a different committee approved separate legislation to provide employment protections for people who use marijuana. Another panel advanced a similar cannabis employment protections bill in September.

Meanwhile, the head of Massachusetts’s marijuana regulatory agency recently suggested that the measure to effectively recriminalize recreational cannabis sales could imperil tax revenue that’s being used to support substance misuse treatment efforts and other public programs.

To that point, Massachusetts recently reached another marijuana milestone, with officials announcing in February that the state has surpassed $9 billion in adult-use cannabis purchases since the market launched in 2018.

A report from the Cannabis Control Commission (CCC) found that legalization is achieving one of its primary goals: disrupting illicit cannabis sales as adults transition to the regulated market. It shows that among adults who reported past-year marijuana use, an overwhelming 84 percent said they obtained their cannabis from a licensed source.

Massachusetts lawmakers also recently assembled a bicameral conference committee to reach a deal on a bill that would double the legal marijuana possession limit for adults and revise the regulatory framework for the state’s adult-use cannabis market.

In December, state regulators also finalized rules for marijuana social consumption lounges.

CCC recently launched an online platform aimed at helping people find jobs, workplace training and networking opportunities in the state’s legal cannabis industry.

Separately, lawmakers are also advancing legislation to establish pilot programs for the regulated therapeutic use of psychedelics.

Maine Lawmakers Reject Bill To Legalize Marijuana Consumption Lounges

A Maine Republican lawmaker is calling out colleagues for killing his bill that would have allowed marijuana consumption lounges to operate in the state.

On Monday, the House of Representatives voted 108-35 to adopt a committee’s recommendation not to pass the bill, LD 1365 from Rep. David Boyer (R).

The lawmaker said members of his own party were “about split” on the vote, wheres the “vast majority” of Democrats voted against allowing his cannabis legislation to advance.

Only seven Democrats voted against the Veterans and Legal Affairs Committee’s majority report recommending that the bill not pass, while 65 members of the party supported the move to kill the legislation.

Among Republicans, 28 members voted against stalling the measure while 41 backed the motion.

“Maine lawmakers showed their contempt for voters today by killing the cannabis hospitality lounge bill,” Boyer, who led the fight to pass cannabis legalization at the ballot about 10 years ago when he was a staffer for the Marijuana Policy Project (MPP), told Marijuana Moment.

“This was a core provision of the 2016 citizens initiative that Maine voters approved nearly ten years ago to legalize adult-use cannabis and create safe, regulated social consumption spaces,” he said, referring to portions of the legalization ballot measure that were later negotiated out by the legislature’s Marijuana Legalization Implementation Committee.

“There is no good reason to prohibit cannabis hospitality lounges when we allow adults to consume alcohol in public,” Boyer said “It’s time uphold the will of the voters and let adults be adults.”

Under the bill, municipalities would be able to license cannabis hospitality lounges where adults over the age of 21 could consume marijuana products. Local officials could also set fees on the businesses.

After being locally licensed, the facilities would not need additional approval from the Maine Office of Cannabis Policy or other state officials.

—Marijuana Moment is tracking hundreds of cannabis, psychedelics and drug policy bills in state legislatures and Congress this year. Patreon supporters pledging at least $25/month get access to our interactive maps, charts and hearing calendar so they don’t miss any developments.

Learn more about our marijuana bill tracker and become a supporter on Patreon to get access.—

Meanwhile, a Maine campaign seeking to significantly roll back the state’s marijuana law failed to submit signatures by a recent deadline to make the November 2026 ballot, meaning the anti-cannabis activists will need to shift their focus to 2027 if they hope to put the issue before voters.

If approved, the initiative would end regulated recreational marijuana sales as approved by voters in 2016. Possession of up to 2.5 ounces of cannabis would remain legal, but adults would no longer be able to grow plants for personal use or buy adult-use cannabis from licensed stores.

The campaign behind the measure has criticism from reform advocates, industry stakeholders and certain lawmakers over allegedly misleading signature gathering tactics,

Photo courtesy of Mike Latimer.

Drug Reform Group Lays Out Options To Address High-THC Marijuana’s Risks Without Returning To Criminalization

Advocates have long argued that marijuana legalization is a superior alternative to criminalization. But while that sentiment prevails with the public and a growing number of lammakers, a leading drug policy reform group says it’s nonetheless important to recognize and address potential public health impacts of consumer trends in state-regulated markets—including the rise of high-potency THC products.

Prohibitionists have been quick to seize upon reports of adverse health incidents associated with products engineered to maximize THC, whether it’s naturally produced delta-9 THC in marijuana, synthetically manufactured delta-8 THC in hemp or any of the numerous other iterations of the intoxicating cannabinoid.

But rather than revert to banning such products outright, officials should prioritize targeted regulations to balance public health and consumer choice, the pro-legalization Drug Policy Alliance (DPA) said in a new report titled “High-THC Marijuana: Protecting Public Health In A Changing Market.”

“As product potency rises, so do important public health questions about safety, youth access, and consumer transparency,” it says, adding that DPA’s position is that “legalization must be paired with thoughtful, evidence-based regulation that protects health, enhances safety, and reduces harm.”

The organization isn’t necessarily arguing that high-THC cannabis products present an imminent public health threat, pointing to the “mixed body of research” on the potential negative health impacts such as the development of cannabis use disorder, anxiety and other mental health conditions. But there is a need to expand research into the issue and inform public policy, particularly as it concerns youth use and access, DPA said.

For some patients, higher concentrations of THC can “help manage pain and other medical conditions,” the report said, so regulations should “consider medical exemptions or alternate provisions to accommodate these patients’ needs.” At the same time, one of the group’s recommendations is to ensure that legal markets offer a diversified array of products that includes low-THC options for patients and consumers.

Overall, one of DPA’s top recommendations is to create a “unified regulatory framework for all cannabinoids (including hemp-derived products like delta-8 THC) with consistent standards for testing, labeling, age restrictions, and consumer protections.”

Other proposals essentially follow the same line of policy thinking that reform advocates have long pushed for as an alternative to criminalizing cannabis. That is, they want to see research (including opportunities for federal studies) expanded, restrictions such as age-gating enforced to mitigate youth access and tax revenue allocations that support mental health treatment and other public health initiatives.

There should also be improvements in “consumer education and product transparency with standardized serving sizes, clear THC content labeling, prominent warning labels, retail education materials, and training for dispensary staff,” the report says.

Because there may be health impacts associated with high-THC cannabis, policymakers should additionally consider potential alternatives to blanket bans that still aim to steer the market away from becoming oversaturated with such products. That could include setting prices based in part on THC potency, while also requiring low-THC product availability in the regulated market.

Although the science and health impacts of high-THC cannabis is still being studied, one thing is undeniable: There has been a steady rise in the marketing and sale of such products as the state legalization movement has expanded and businesses have responded to consumer demand. DPA’s report is meant to respond to that reality, without ceding the issue to anti-legalization interests that have used fears about the use of these highly potent products to promote prohibitionist policies.

Cat Packer, DPA’s director of legal regulation, said in a Q&A about the THC potency issue that “no one should be arrested for marijuana and policies cannot return to bringing back harmful and ineffective criminalization tactics.”

“Legal regulation must address the ongoing harms of criminalization that impede on someone’s livelihood and basic needs,” she said. “At minimum, clearing records for all past marijuana arrests and convictions. Not having a criminal record removes barriers to economic opportunities and housing access. Ending criminalization also stops law enforcement from targeting certain communities.”

The DPA report concludes by reiterating that high-THC marijuana products “pose complex regulatory challenges that demand a balanced, evidence-based response.”

“As product potency increases and markets evolve, policy must keep pace. Failing to modernize regulatory frameworks poses threats to public health, particularly for youth and individuals vulnerable to mental and physical health issues and substance use disorders,” it says.

“By aligning hemp and marijuana regulations, strengthening research and data collection, improving product transparency, and implementing safeguards for high-THC products, policymakers can reduce preventable harms while preserving access for adult consumers and medical patients,” it continues. “Public education, responsible retail practices, and reinvestment of tax revenue into treatment and prevention are critical to regulation that balances commercial interests with public health.”

Aligning hemp and marijuana rules has become all the more urgently needed as the federal definition of hemp is set to fundamentally change later this year, with a significantly more restrictive threshold for THC to be considered legal hemp. Industry stakeholders say that policy change, which is set to take effect in November under a broader agriculture law President Donald Trump enacted last year, threatens to effectively eradicate the consumable cannabinoid market.

“A strong regulatory framework that is grounded in evidence, health, and consumer protections offers the clearest path forward,” DPA said. “Policymakers should heed these recommendations to mitigate risks, promote informed decision-making, and ensure market innovations do not outpace health protections.”

Meanwhile, amid shifting state and federal cannabis policies, the White House has scheduled several meetings with cannabis industry and research stakeholders to discuss a proposed enforcement policy for non-intoxicating CBD products.

Also in the background, advocates and stakeholders are also eagerly awaiting the finalization of a rule to move marijuana from Schedule I to Schedule III of the Controlled Substances Act (CSA). Trump signed an executive order in December directing the attorney general to expeditiously complete that process—which would help streamline cannabis research while allowing state-licensed businesses to take federal tax deductions—but that remains pending.